Pfizer is asking the FDA to allow emergency use of its COVID-19 vaccine candidate, starting a process that could bring the first shots as early as next month. Pfizer and its German partner BioNTech offered preliminary data to suggest its vaccine appears 95% protective. Health experts say it likely will be spring or later before there’s enough vaccine for early distribution to the general public. ———NEW YORK — Pfizer will ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month. The announcement comes days after Pfizer and its German partner BioNTech offered preliminary data to suggest its vaccine appears 95% protective.

Source: Daily Sun November 20, 2020 07:45 UTC